Tower and Drexel, with the backing of the University of Pennsylvania Health System, also teamed up in a separate auction last month for Hahnemann’s residency programs, but lost to Jefferson’s $55 million bid. Federal regulators are trying to block that sale in U.S. District Court in Delaware, where the parent company of Hahnemann and St. Christopher’s filed for bankruptcy.